Location of Repository

Cancer chemopreventive properties of anthocyanins in patients with colorectal cancer and colorectal liver metastases

By Sarah Carol Thomasset


Anthocyanins, polyphenolic phytochemicals which render fruit and vegetables bright red or blue, possess anticarcinogenic properties in preclinical models of carcinogenesis. The aim of this study was to elucidate whether consumption of mirtocyan, a standardised anthocyanin extract, would cause pharmacodynamic changes consistent with chemoprevention and generate measurable levels of anthocyanins in blood, urine and target tissue.\ud Twenty-five patients with either primary colorectal cancer or colorectal liver metastases received 1.4, 2.8 or 5.6 g of mirtocyan (containing 0.5-2.0 g anthocyanins) daily for 7 days prior to colon/liver resection. Anthocyanin levels were measured by high performance liquid chromatography. Proliferation (Ki-67), apoptosis (caspase-3) and inflammation (COX-2) were measured in colorectal tumour tissue. Effects on the insulin-like growth factor (IGF) axis were evaluated in plasma and markers of oxidative DNA damage were assessed in blood and urine.\ud Consumption of up to 5.6 g of mirtocyan daily was well tolerated. Analysis of colorectal tumour tissue revealed that consumption of mirtocyan was associated with a 7% decrease in proliferation (p=0.003) and a 1.7% increase in apoptosis (0.044). A trend towards a reduction in circulating IGF-1 levels was observed (p=0.168). Mirtocyan anthocyanins and methyl and glucuronide metabolites were identified in plasma, urine and colorectal tissue, but not in liver. Anthocyanin concentrations in biomatrices were approximately dose-dependent. Following consumption of 5.6 g of mirtocyan daily anthocyanin levels in plasma, urine and colorectal tumour tissue were 117 ng/ml, 3 μg/ml and 179 ng/g, respectively. Mirtocyan did not affect levels of COX-2 or markers of oxidative DNA damage.\ud Administration of mirtocyan furnished levels of anthocyanins in colorectal tumour tissue comparable to those capable of mediating chemopreventive effects in vivo. Consumption of only 1.4 g of mirtocyan daily may exert pharmacodynamic effects commensurate with colorectal cancer chemoprevention. These data support further clinical development of anthocyanins as potential colorectal cancer chemopreventive agents

Publisher: University of Leicester
Year: 2009
OAI identifier: oai:lra.le.ac.uk:2381/7515

Suggested articles



  1. (2008). A 90-day oral toxicity study of purple corn color, a natural food colorant, in F344 rats.
  2. (2006). A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
  3. Absorption and excretion of black currant anthocyanins in humans and watanabe heritable hyperlipidemic rabbits.
  4. (2007). Absorption and excretion of elderberry (Sambucus nigra L.) anthocyanins in healthy humans.
  5. (2002). Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry.
  6. (2002). Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects.
  7. (2006). Absorption of anthocyanins from blueberry extracts by caco-2 human intestinal cell monolayers.
  8. (2007). Absorption of Bilberry Anthocyanins, Putative Colorectal Cancer Chemopreventive Agents, from the Gastrointestinal Tract of Patients with Hepatic Metastases Sarah Thomasset, Hong Cai
  9. (2006). Absorption, tissue distribution and excretion of pelargonidin and its metabolites following oral administration to rats.
  10. (2005). Aglycones and sugar moieties alter anthocyanin absorption and metabolism after berry consumption in weanling pigs.
  11. (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.
  12. An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice.
  13. (2006). An anthocyanin/polyphenolic-rich fruit juice reduces oxidative DNA damage and increases glutathione level in healthy probands.
  14. (2003). An improved liquid chromatography/tandem mass spectrometry method for the determination of 8-oxo-7,8-dihydro-2'-deoxyguanosine in DNA samples using immunoaffinity column purification.
  15. (2003). Analysis and biological activities of anthocyanins.
  16. (2005). Analysis of anthocyanins in rat intestinal contents - Impact of anthocyanin structure on fecal excretion.
  17. (2003). Anthocyanidins induce apoptosis in human promyelocytic leukemia cells: structure-activity relationship and mechanisms involved.
  18. (2005). Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure-activity relationship and molecular mechanisms involved.
  19. (2008). Anthocyanin excretion by humans increases linearly with increasing strawberry dose.
  20. Anthocyanin fraction from potato extracts is cytotoxic to prostate cancer cells through activation of caspase-dependent and caspase-independent pathways.
  21. (2003). Anthocyanin glycosides from berry fruit are absorbed and excreted unmetabolized by both humans and rats.
  22. (2005). Anthocyanin metabolism in rats and their distribution to digestive area, kidney, and brain.
  23. (2004). Anthocyanin metabolites in human urine and serum.
  24. (2001). Anthocyanin-rich extract decreases indices of lipid peroxidation and DNA damage in vitamin E-depleted rats.
  25. (2003). Anthocyanin-rich extract from Aronia meloncarpa E induces a cell cycle block in colon cancer but not normal colonic cells.
  26. (2006). Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats.
  27. (2005). Anthocyaninand hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NFkappaB pathways and inhibits skin tumorigenesis in CD-1 mice.
  28. (2004). Anthocyanins are efficiently absorbed from the small intestine in rats.
  29. (2003). Anthocyanins are efficiently absorbed from the stomach in anesthetized rats.
  30. (2005). Anthocyanins exist in the circulation primarily as metabolites in adult men.
  31. (2005). Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory.
  32. (2004). Anthocyanins induce cell cycle perturbations and apoptosis in different human cell lines.
  33. (2005). Anthocyans from fruits and vegetables--does bright colour signal cancer chemopreventive activity?
  34. (2002). Antioxidant activity of black currant anthocyanin aglycons and their glycosides measured by chemiluminescence in a neutral pH region and in human plasma.
  35. (2004). Antioxidant and cellular activities of anthocyanins and their corresponding vitisins A--studies in platelets, monocytes, and human endothelial cells.
  36. (2008). Antioxidants and the Comet assay. Mutat Res.
  37. (2007). Berry phenolic extracts modulate the expression of p21(WAF1) and Bax but not Bcl-2 in HT-29 colon cancer cells.
  38. (2006). Bioavailability and tissue distribution of anthocyanins in bilberry (Vaccinium myrtillus L.) extract in rats.
  39. (2003). Bioavailability of anthocyanidin-3-glucosides following consumption of red wine and red grape juice.
  40. (2004). Bioavailability of anthocyanidin-3-glycosides following consumption of elderberry extract and blackcurrant juice.
  41. (2008). Bioavailability of pelargonidin-3-O-glucoside and its metabolites in humans following the ingestion of strawberries with and without cream.
  42. (2004). Biological relevance of adduct detection to the chemoprevention of cancer.
  43. (2006). Black raspberries inhibit N-nitrosomethylbenzylamine (NMBA)-induced angiogenesis in rat esophagus parallel to the suppression of COX-2 and iNOS.
  44. (2006). Black rice anthocyanins inhibit cancer cells invasion via repressions of MMPs and uPA expression.
  45. (2005). Blackberry anthocyanins are mainly recovered from urine as methylated and glucuronidated conjugates in humans.
  46. (2006). Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro.
  47. (2001). Cancer chemoprevention by dietary constituents: a tale of failure and promise.
  48. (2005). Cancer chemoprevention: lessons learned and future directions.
  49. (2002). Cancer chemoprevention.
  50. (2007). Cancer prevention with freeze-dried berries and berry components.
  51. (1994). Carotene Prevention Study Group.
  52. (2006). Celecoxib for the prevention of colorectal adenomatous polyps.
  53. (2006). Celecoxib for the prevention of sporadic colorectal adenomas.
  54. (2002). Chemoprevention of colorectal carcinogenesis.
  55. (2001). Chemoprevention of esophageal tumorigenesis by dietary administration of lyophilized black raspberries.
  56. (2003). Chemoprevention of lung carcinogenesis by cacao liquor proanthocyanidins in a male rat multi-organ carcinogenesis model.
  57. (2002). Chemoprevention of oral cancer by black raspberries.
  58. (2007). Colon-available raspberry polyphenols exhibit anti-cancer effects on in vitro models of colon cancer.
  59. (2004). Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs.
  60. (2005). Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
  61. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.
  62. (2005). Cyanidin 3-glucoside and peonidin 3-glucoside inhibit tumor cell growth and induce apoptosis in vitro and suppress tumor growth in vivo.
  63. (2006). Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity.
  64. (2007). Cyanidin-3-rutinoside, a natural polyphenol antioxidant, selectively kills leukemic cells by induction of oxidative stress.
  65. (2001). Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries.
  66. (1998). Cyclooxygenase regulates angiogenesis induced by colon cancer cells.
  67. (2005). Cyclooxygenase-2 (COX-2) levels before and after chemotherapy: a study in rectal cancer.
  68. (2000). Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients.
  69. (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential.
  70. (2004). Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.
  71. (1996). Cyclooxygenase-2 messenger RNA induction in focal cerebral ischemia.
  72. (2005). Delphinidin 3-sambubioside, a Hibiscus anthocyanin, induces apoptosis in human leukemia cells through reactive oxygen species-mediated mitochondrial pathway.
  73. (2006). Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation.
  74. (2007). Delphinidin, an anthocyanidin in pigmented fruits and vegetables, protects human HaCaT keratinocytes and mouse skin against UVBmediated oxidative stress and apoptosis.
  75. (2001). Determination of anthocyanidins in berries and red wine by high-performance liquid chromatography.
  76. (1998). Determination of malondialdehyde-induced DNA damage in human tissues using an immunoslot blot assay.
  77. Development of analyses by high-performance chromatography/tandem mass spectrometry of bilberry (Vaccinium myrtilus) anthocyanins in human plasma and urine.
  78. (2006). Development of analyses by highperformance liquid chromatography and liquid chromatography/tandem mass spectrometry of bilberry (Vaccinium myrtilus) anthocyanins in human plasma and urine.
  79. (2006). Dietary anthocyanin-rich tart cherry extract inhibits intestinal tumorigenesis in APC(Min) mice fed suboptimal levels of sulindac.
  80. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study.
  81. Dietary polyphenolic phytochemicals – Promising cancer chemopreventive agents in humans? A review of their clinical properties.
  82. (2007). Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties.
  83. (2008). Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial. Cancer Prev Res,
  84. (1999). Direct intestinal absorption of red fruit anthocyanins, cyanidin-3-glucoside and cyanidin-3,5-diglucoside, into rats and humans.
  85. (1991). Distribution of UDPglucuronosyltransferase and its endogenous substrate uridine 5'-diphosphoglucuronic acid in human tissues.
  86. (2005). DNA stability and lipid peroxidation in vitamin Edeficient rats in vivo and colon cells in vitro--modulation by the dietary anthocyanin, cyanidin-3-glycoside.
  87. (2007). Effect of anthocyanin fractions from selected cultivars of Georgia-grown blueberries on apoptosis and phase II enzymes.
  88. (2006). Effect of cyanidin-3-glucoside and an anthocyanin mixture from bilberry on adenoma development in the ApcMin mouse model of intestinal carcinogenesis--relationship with tissue anthocyanin levels.
  89. (2007). effect of dose size on bioavailability of acylated and nonacylated anthocyanins from red cabbage (Brassica oleracea L.
  90. (2005). Effects of 9-cis-retinoic acid on the insulin-like growth factor axis in former smokers.
  91. (1996). Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
  92. (2008). Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions.
  93. (2005). Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells.
  94. (2005). Effects of blood orange juice intake on antioxidant bioavailability and on different markers related to oxidative stress.
  95. (2001). Effects of lyophilized black raspberries on azoxymethane-induced colon cancer and 8-hydroxy2'-deoxyguanosine levels in the Fischer 344 rat.
  96. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutrition prevention of Cancer Study group.
  97. (2005). EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells.
  98. (2005). Genistein inhibits insulin-like growth factor-I receptor signaling in HT-29 human colon cancer cells: a possible mechanism of the growth inhibitory effect of Genistein.
  99. (2003). Genotoxicity, recombinogenicity and cellular preneoplasic transformation induced by vitamin A supplementation.
  100. (2005). Global cancer statistics,
  101. (2005). Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities.
  102. (2005). Hibiscus anthocyanins rich extract-induced apoptotic cell death in human promyelocytic leukemia cells.
  103. (2005). How good are rodent models of carcinogenesis in predicting efficacy in humans? A systematic review and meta-analysis of colon chemoprevention in rats, mice and men.
  104. (2005). Human tumor cell growth inhibition by nontoxic anthocyanidins, the pigments in fruits and vegetables.
  105. (2008). Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs.
  106. (2005). In vitro metabolism of anthocyanins by human gut microflora.
  107. (2005). Induction of apoptosis by the Anthocyanidins through regulation of Bcl-2 gene and activation of c-Jun N-terminal kinase cascade in hepatoma cells.
  108. (2003). Induction of apoptosis in cancer cells by Bilberry (Vaccinium myrtillus) and the anthocyanins.
  109. (2004). Inhibition of cancer cell proliferation in vitro by fruit and berry extracts and correlations with antioxidant levels.
  110. (2004). Inhibition of malonaldehyde formation in oxidized calf thymus DNA with synthetic and natural antioxidants.
  111. (2003). Inhibition of proliferation of human cancer cells and cyclooxygenase enzymes by anthocyanidins and catechins.
  112. (2007). Limited stability in cell culture medium and hydrogen peroxide formation affect the growth inhibitory properties of delphinidin and its degradation product gallic acid.
  113. (2006). Low folate levels may protect against colorectal cancer.
  114. (2001). Malvidin-3-glucoside bioavailability in humans after ingestion of red wine, dealcoholized red wine and red grape juice.
  115. (2005). Metabolic pathway of cyanidin 3-O-beta-D-glucopyranoside in rats.
  116. (2006). Mulberry anthocyanins, cyanidin 3-rutinoside and cyanidin 3-glucoside, exhibited an inhibitory effect on the migration and invasion of a human lung cancer cell line.
  117. (2001). Orally administered delphinidin 3-rutinoside and cyanidin 3-rutinoside are directly absorbed in rats and humans and appear in the blood as the intact forms.
  118. (2000). Perspectives on surrogate end points in the development of drugs that reduce the risk of cancer.
  119. (2005). Pharmacokinetics of anthocyanins and ellagic acid in healthy volunteers fed freeze-dried black raspberries daily for 7 days.
  120. (2005). Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis.
  121. (2005). Plasma and urine responses are lower for acylated vs nonacylated anthocyanins from raw and cooked purple carrots.
  122. (2002). Prevention by natural food anthocyanins, purple sweet potato color and red cabbage color, of 2-amino-1-methyl6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in rats initiated with 1,2-dimethylhydrazine.
  123. (1999). Prevention of cancer in the next millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research.
  124. (2006). Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forward.
  125. (2001). Proliferation, cell cycle and apoptosis in cancer.
  126. (2001). Pronounced inhibition by a natural anthocyanin, purple corn color, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-associated colorectal carcinogenesis in male F344 rats pretreated with 1,2-dimethylhydrazine.
  127. (1999). Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
  128. (2002). Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy.
  129. (2008). Publications related to this research
  130. (2005). Purified high-dose anthocyanoside oligomer administration improves nocturnal vision and clinical symptoms in myopia subjects.
  131. (2006). Purple grape juice inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation.
  132. (1966). Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.
  133. (2001). Redundancy in the signaling pathways and promoter elements regulating cyclooxygenase-2 gene expression in endotoxin-treated macrophage/monocytic cells.
  134. (2007). Role of mitogen-activated protein kinase phosphatases (MKPs) in cancer.
  135. (2003). Serum insulinlike growth factor I and subsequent risk of colorectal cancer among JapaneseAmerican men.
  136. (2003). Strawberry anthocyanins are recovered in urine as glucuro- and sulfoconjugates in humans.
  137. (2003). Tart cherry anthocyanins inhibit tumor development in Apc(Min) mice and reduce proliferation of human colon cancer cells.
  138. (2001). The anthocyanidins cyanidin and delphinidin are potent inhibitors of the epidermal growth-factor receptor.
  139. (2007). The bioavailability and absorption of anthocyanins: Towards a better understanding.
  140. (2002). The effect of wild blueberry (Vaccinium angustifolium) consumption on postprandial serum antioxidant status in human subjects.
  141. (2006). The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers.
  142. (2006). The jejunum is the main site of absorption for anthocyanins in mice.
  143. (2002). The metabolism of dietary polyphenols and the relevance to circulating levels of conjugated metabolites.
  144. (1999). The relationship between cyclooxygenase-2 expression and colorectal cancer.
  145. (2003). The stomach as a site for anthocyanins absorption from food.
  146. (2004). The substitution pattern of anthocyanidins affects different cellular signaling cascades regulating cell proliferation.
  147. (1988). Time course of release in vivo of PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and TxB2 into the brain extracellular space after 15 min of complete global ischemia in the presence and absence of cyclooxygenase inhibition.
  148. (2006). Transitioning from preclinical to clinical chemopreventive assessments of lyophilized black raspberries: interim results show berries modulate markers of oxidative stress in Barrett's esophagus patients.
  149. (2002). Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development.
  150. (2006). Urinary excretion of anthocyanins in humans after cranberry juice ingestion.
  151. (2002). Urinary excretion of cyanidin glycosides.
  152. (2005). Urinary pharmacokinetics of cyanidin glycosides in healthy young men following consumption of elderberry juice.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.